123 related articles for article (PubMed ID: 38386015)
1. Diagnostic and prognostic value of serum soluble B7-H3 in nonsmall cell lung cancer.
Li Y; Xu L; Li J; Wang Q; Ma J
Anticancer Drugs; 2024 Jun; 35(5):426-432. PubMed ID: 38386015
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging.
Chen L; Zhang G; Sheng S; Zhou Q; Pan Y; Guan S
Clin Chim Acta; 2016 Jun; 457():81-5. PubMed ID: 27071700
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma.
Huang L; Zhou Y; Sun Q; Cao L; Zhang X
Cancer Biomark; 2022; 33(1):123-129. PubMed ID: 34459388
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer.
Zhang G; Xu Y; Lu X; Huang H; Zhou Y; Lu B; Zhang X
Lung Cancer; 2009 Nov; 66(2):245-9. PubMed ID: 19269710
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Genova C; Tasso R; Rosa A; Rossi G; Reverberi D; Fontana V; Marconi S; Croce M; Dal Bello MG; Dellepiane C; Tagliamento M; Ciferri MC; Zullo L; Fedeli A; Alama A; Cortese K; Gentili C; Cella E; Anselmi G; Mora M; Barletta G; Rijavec E; Grossi F; Pronzato P; Coco S
Cells; 2023 Mar; 12(6):. PubMed ID: 36980174
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer.
Azuma T; Sato Y; Ohno T; Azuma M; Kume H
PLoS One; 2020; 15(12):e0243379. PubMed ID: 33306717
[TBL] [Abstract][Full Text] [Related]
7. Value of bile soluble B7H3 for the diagnosis of malignant biliary strictures: Results of a retrospective study.
Liu Y; Cheng C; Bai L; Yao F; Shi S; Zhang Y
Surg Oncol; 2019 Mar; 28():195-200. PubMed ID: 30851900
[TBL] [Abstract][Full Text] [Related]
8. Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3.
Zhao L; Xie C; Liu D; Li T; Zhang Y; Wan C
J Gastrointest Surg; 2017 May; 21(5):807-812. PubMed ID: 28243980
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer.
Xu CH; Wang W; Wang YC; Lin Y; Zhang XW
Clin Respir J; 2018 Jan; 12(1):134-139. PubMed ID: 27216449
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma].
Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248
[TBL] [Abstract][Full Text] [Related]
11. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
12. Soluble B7-H3 in Colorectal Cancer.
Kovaleva OV; Gratchev AN; Sokolov NY; Maslennikov VV; Kuzmin YB; Gershtein ES; Alferov AA; Mamedli ZZ; Stilidi IS; Kushlinskii NE
Bull Exp Biol Med; 2023 Nov; 176(1):87-90. PubMed ID: 38085395
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum soluble B7-H3 in patients with osteosarcoma.
Wang L; Kang FB; Zhang GC; Wang J; Xie MF; Zhang YZ
Cancer Cell Int; 2018; 18():115. PubMed ID: 30123093
[TBL] [Abstract][Full Text] [Related]
14. The correlation of serum sPD-1 and sPD-L1 levels with clinical, pathological characteristics and lymph node metastasis in nonsmall cell lung cancer patients.
Ancın B; Özercan MM; Yılmaz YM; Uysal S; Kumbasar U; Sarıbaş Z; Dikmen E; Doğan R; Demircin M
Turk J Med Sci; 2022 Aug; 52(4):1050-1057. PubMed ID: 36326416
[TBL] [Abstract][Full Text] [Related]
15. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
17. [Plasma sB7-H3 serves as an assistant diagnostic marker for hepatitis B virus-associated hepatocellular carcinoma].
Xu W; Li F; Yu L; Liu J; He X; Fan R; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):744-7. PubMed ID: 25001942
[TBL] [Abstract][Full Text] [Related]
18. Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.
Xie C; Liu D; Chen Q; Yang C; Wang B; Wu H
Sci Rep; 2016 Jun; 6():27528. PubMed ID: 27273624
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum B7-H3 expression, ultrasound and clinical characteristics to predict the risk of cervical lymph node metastases in papillary thyroid carcinoma by nomogram.
Huang Y; Huang Z; Cai H; Zhuge L; Wang S; Yan D; Zhang X; An C; Niu L; Li Z
J Clin Lab Anal; 2023 Jan; 37(1):e24811. PubMed ID: 36525343
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of membrane B7-H3 costimulatory molecule but reduction of its soluble form in multiple sclerosis.
Jiang J; Jiang J; Liu C; Zhang G; Gao L; Chen Y; Zhu R; Wang T; Wang F; Zhang X; Xue Q
J Clin Immunol; 2013 Jan; 33(1):118-26. PubMed ID: 22996270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
